The Department of Life Technologies at University of Turku has awarded the Title of Docent (Adjunct Professor) in Computational Biology to Senior postdoctoral researcher, Dr. Partho Sen
After completing his PhD in ‘Biological Sciences’ (Computational Biology) from the University of Montpellier, France he started his career path in Systems biology and medicine, to understand how complex biological systems regulate, adapt and cope under various environmental and physiological conditions. Dr. Sen pursued his first postdoctoral training from the Nielsen’s lab at Chalmers University of Technology, Gothenburg, Sweden working on several projects which involved co-metabolism between the gut microbiota and humans in health and disease. Currently, working as a senior postdoctoral researcher in the Systems Medicine group at Turku Bioscience, University of Turku, Finland, his research spans along different topics such as metabolism in immune cells and Type 1 Diabetes (T1D), Celiac disease progression, non-alcoholic fatty liver disease (NAFLD) and exposomics – with a common goal to understand mechanism(s) that incur dys(regulation) of biochemical processes in health and disease states, and thereby identify molecular markers.
“I am excited to share my vision for scientific research, particularly in approaches that promote the application of high throughput ‘Big’ data, and development of tools to address modern challenges in the healthcare sector, and in cell/tissue biology.” – says Partho
Recent Posts
- Dissertation Defence: Eleftheria MaranouMSc Eleftheria Maranou, from affiliated MIORG group, succesfully defended the dissertation in Immunology titled “The Achilles’ heel of Read moreSeptember 1, 2026
- Researchers discover molecular mechanism that helps aggressive colorectal cancer to spreadResearchers from the University of Turku in Finland, Turku Bioscience Centre and Gustave Roussy Institute Read moreAugust 25, 2026
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026
- BioCity Turku asks for proposals for Elias Tillandz publication prize winner during March 2026In the context of the 35th BioCity Symposium “Vision, Expanded” (27-28 August 2026) the twenty-second Read moreMarch 3, 2026